To test whether the effects of ITGAV dependent survival differences are based on the correlation with tumor stages, a multivariate cox-regression model was performed which showed the tumor stage, lymph node metastasis and ITGAV expression as independent prognostic markers for overall-survival in the group of patients without neoadjuvant treatment (Table 3). The gene discussed is ITGAV; the disease is neoplasm.